87 related articles for article (PubMed ID: 26592829)
1. Decreased preoperative serum fibulin-3 levels in colon cancer patients.
Simsek O; Kocael A; Kemik A; Vatankulu B; Kocael P; Halac M; Ulualp K; Sonmezoglu K
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4076-80. PubMed ID: 26592829
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of fibulin-4 is associated with tumor progression and poor prognosis in patients with cervical carcinoma.
Chen J; Zhang J; Liu X; Fang R; Zhao Y; Ma D
Oncol Rep; 2014 Jun; 31(6):2601-10. PubMed ID: 24737201
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin-M as a novel biomarker in colon cancer patients and its association with clinicopathologic variables.
Gurluler E; Tumay LV; Guner OS; Kucukmetin NT; Hizli B; Zorluoglu A
Eur Rev Med Pharmacol Sci; 2014; 18(14):2042-7. PubMed ID: 25027345
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum levels of mesothelin in patients with colon cancer.
Bostancı O; Kemik O; Kemik A; Battal M; Demir U; Purisa S; Yavuz A; Mihmanlı M
Dis Markers; 2014; 2014():161954. PubMed ID: 25477701
[TBL] [Abstract][Full Text] [Related]
5. A novel screening test for colon cancer: Talin-1.
Bostanci O; Kemik O; Kemik A; Battal M; Demir U; Purisa S; Mihmanli M
Eur Rev Med Pharmacol Sci; 2014; 18(17):2533-7. PubMed ID: 25268101
[TBL] [Abstract][Full Text] [Related]
6. Fibulin-3 as a diagnostic biomarker in patients with malignant mesothelioma.
Kaya H; Demir M; Taylan M; Sezgi C; Tanrikulu AC; Yilmaz S; Bayram M; Kaplan I; Senyigit A
Asian Pac J Cancer Prev; 2015; 16(4):1403-7. PubMed ID: 25743806
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
Pang L; Wang DW; Zhang N; Xu DH; Meng XW
Cancer Biomark; 2016 Mar; 16(4):599-607. PubMed ID: 27002762
[TBL] [Abstract][Full Text] [Related]
8. Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas.
Chen J; Liu Z; Fang S; Fang R; Liu X; Zhao Y; Li X; Huang L; Zhang J
BMC Cancer; 2015 Mar; 15():91. PubMed ID: 25885889
[TBL] [Abstract][Full Text] [Related]
9. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.
Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I
J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728
[TBL] [Abstract][Full Text] [Related]
10. Serum annexin A2 levels in patients with colon cancer in comparison to healthy controls and in relation to tumor pathology.
Gurluler E; Guner OS; Tumay LV; Turkel Kucukmetin N; Hizli B; Zorluoglu A
Med Sci Monit; 2014 Oct; 20():1801-7. PubMed ID: 25287627
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
[TBL] [Abstract][Full Text] [Related]
12. Significance of tenascin serum level as tumor marker in primary colorectal carcinoma.
Riedl S; Bodenmüller H; Hinz U; Holle R; Möller P; Schlag P; Herfarth C; Faissner A
Int J Cancer; 1995 Feb; 64(1):65-9. PubMed ID: 7545144
[TBL] [Abstract][Full Text] [Related]
13. Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma.
De Vita F; Orditura M; Lieto E; Infusino S; Morgillo F; Martinelli E; Castellano P; Romano C; Ciardiello F; Catalano G; Pignatelli C; Galizia G
Cancer; 2004 Jan; 100(2):270-8. PubMed ID: 14716760
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of preoperative and postoperative total serum sialic acid levels in patients with colon cancer.
İliklerden ÜH; Peksen C; Kalayci T; Kemik O
Ann Ital Chir; 2020; 91():649-647. PubMed ID: 33554943
[TBL] [Abstract][Full Text] [Related]
15. Circulating and local nuclear expression of survivin and fibulin-3 genes in discriminating benign from malignant respiratory diseases: correlation analysis.
Hassan MH; Abuhamdah S; Abdel-Bary M; Wahman M; Abd-Elhamid TH; Beshay M; Mosallam K; Elsadek BEM
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33226065
[TBL] [Abstract][Full Text] [Related]
16. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
Lin HH; Chang CC; Yang SH; Chang SC; Chen WS; Liang WY; Lin JK; Jiang JK
World J Surg Oncol; 2016 Mar; 14():84. PubMed ID: 26976278
[TBL] [Abstract][Full Text] [Related]
18. Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients.
Klupp F; Neumann L; Kahlert C; Diers J; Halama N; Franz C; Schmidt T; Koch M; Weitz J; Schneider M; Ulrich A
BMC Cancer; 2016 Jul; 16():494. PubMed ID: 27431388
[TBL] [Abstract][Full Text] [Related]
19. Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.
Aydin MA; Gul G; Kiziltan R; Algul S; Kemik O
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10512-10517. PubMed ID: 33155206
[TBL] [Abstract][Full Text] [Related]
20. Serum laminin is an independent prognostic factor in colorectal cancer.
Saito N; Kameoka S
Int J Colorectal Dis; 2005 May; 20(3):238-44. PubMed ID: 15592676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
